Is Growth of Coagulase-Negative Staphylococcus epidermidis from Intra-abdominal Fluid Pathological?
Growth of coagulase-negative Staphylococcus epidermidis from intra-abdominal fluid is usually NOT pathogenic and should be interpreted as a contaminant in most clinical scenarios, unless specific high-risk features are present.
Clinical Context and Interpretation
The determination of whether CNS (including S. epidermidis) represents true infection versus contamination in intra-abdominal fluid requires careful clinical correlation:
When to Consider It a Contaminant (Most Common)
- CNS, including S. epidermidis, are normal skin flora and frequently contaminate cultures during specimen collection 1, 2
- In surgical site infections, enterococci and CNS are commonly isolated from superficial cultures but are seldom true pathogens; therapeutic regimens that don't cover these organisms are typically successful 1
- Historical data shows that only 22% of CNS isolates from wounds and body fluids were clinically significant, with the majority being S. epidermidis 3
- The most common source of clinically relevant CNS was wounds, not intra-abdominal fluid 3
When to Consider It Pathogenic (Specific Circumstances)
CNS should be considered pathogenic in intra-abdominal fluid when:
- Foreign body present: Indwelling devices, surgical mesh, or prosthetic material 2, 4, 5
- Immunocompromised host: Patients with significant immune deficiency 2, 4
- Peritoneal dialysis patients: CNS are a recognized cause of peritonitis in continuous ambulatory peritoneal dialysis 1, 2
- Multiple positive cultures: Same organism isolated from multiple specimens or blood cultures
- Clinical signs of infection: Fever, peritoneal signs, elevated inflammatory markers with no other source identified
- Failed initial therapy: Patient not responding to empiric antimicrobial coverage
Practical Approach to Interpretation
Step 1: Assess Collection Method
- Swab specimens are suboptimal and increase contamination risk 6
- Tissue, aspirates, or fluid inoculated into blood culture bottles are more reliable 6
- If collected via swab, interpret positive CNS with extreme skepticism
Step 2: Evaluate Clinical Context
- Is there a foreign body or prosthetic material?
- Is the patient immunocompromised?
- Are there clinical signs of ongoing infection?
- Did the patient fail appropriate empiric therapy?
Step 3: Review Culture Details
- Single positive culture with CNS = likely contaminant
- Multiple cultures with same organism = more likely pathogenic
- Heavy growth vs. light growth (though this alone is insufficient)
Key Guideline Recommendations
The 2024 IDSA guidelines on complicated intra-abdominal infections emphasize that peritoneal fluid cultures are most valuable for identifying less common or multidrug-resistant organisms, including Candida species 6. The guidelines do not specifically highlight CNS as a common pathogen requiring targeted therapy in intra-abdominal infections.
For complicated intra-abdominal infections, positive peritoneal cultures are most useful when patients fail therapy, experience recurrence, or have multidrug-resistant organisms 6. CNS does not fall into the category of organisms that typically require treatment modification in this setting.
Common Pitfalls to Avoid
- Do not treat CNS from intra-abdominal fluid reflexively without clinical correlation
- Avoid using swabs for intra-abdominal specimen collection—this dramatically increases contamination rates 6
- Do not assume all positive cultures require treatment—this leads to unnecessary antibiotic exposure, C. difficile risk, and promotion of antimicrobial resistance 6
- Recognize that CNS are increasingly resistant: 55-75% of nosocomial CNS isolates are methicillin-resistant 2
When Treatment May Be Warranted
If you determine CNS is truly pathogenic based on the criteria above:
- Vancomycin is typically required given high rates of methicillin resistance 2, 5
- Remove foreign bodies when possible—CNS infections associated with devices rarely clear without removal 2, 4
- Prolonged IV therapy is usually necessary due to biofilm formation and antibiotic resistance 5
The distinction between pathogen and contaminant is critical, as inappropriate treatment of contaminants drives antibiotic resistance and patient harm without clinical benefit 6.